Lower incidence of macrovascular complications in patients on insulin glargine versus those on basal human insulins: a population-based cohort study in Italy.

MLA

Cammarota, S., et al. “Lower Incidence of Macrovascular Complications in Patients on Insulin Glargine versus Those on Basal Human Insulins: A Population-Based Cohort Study in Italy.” Nutrition, Metabolism, and Cardiovascular Diseases : NMCD, vol. 24, no. 1, Jan. 2014, pp. 10–17. EBSCOhost, https://doi.org/10.1016/j.numecd.2013.04.002.

APA

Cammarota, S., Bruzzese, D., Catapano, A. L., Citarella, A., De Luca, L., Manzoli, L., Masulli, M., Menditto, E., Mezzetti, A., Riegler, S., Putignano, D., Tragni, E., Novellino, E., & Riccardi, G. (2014). Lower incidence of macrovascular complications in patients on insulin glargine versus those on basal human insulins: a population-based cohort study in Italy. Nutrition, Metabolism, and Cardiovascular Diseases : NMCD, 24(1), 10–17. https://doi.org/10.1016/j.numecd.2013.04.002

Chicago

Cammarota, S, D Bruzzese, A L Catapano, A Citarella, L De Luca, L Manzoli, M Masulli, et al. 2014. “Lower Incidence of Macrovascular Complications in Patients on Insulin Glargine versus Those on Basal Human Insulins: A Population-Based Cohort Study in Italy.” Nutrition, Metabolism, and Cardiovascular Diseases : NMCD 24 (1): 10–17. doi:10.1016/j.numecd.2013.04.002.